Efficacy and safety of nimotuzumab in unresectable, recurrent, and/or metastatic squamous cell carcinoma of the head and neck: A hospital-based retrospective evidence

por Subramanian, Sundaram, Sridharan, Nithya, Balasundaram, V., Chaudhari, Sameer
Publicado 2018

Effectiveness and tolerability of nimotuzumab in unresectable, locally advanced/metastatic esophageal cancer: Indian hospital-based retrospective evidence

por Subramanian, Sundaram, Sridharan, Nithya, Balasundaram, V., Chaudhari, Sameer
Publicado 2019

Real-World Outcomes of Hodgkin Lymphoma: A Multi-Centric Registry From India

por Bhurani, Dinesh, Nair, Reena, Rajappa, Senthil, Rao, Suparna Ajit, Sridharan, Nithya, Boya, Rakesh Reddy, Raman, Ganapathi S., Menon, Hari, Seshachalam, Arun, Nimmagadda, Ramesh
Publicado 2022

Oncology Gold Standard(®) practical consensus recommendations for the use of monoclonal antibodies in the management of squamous cell carcinoma of head and neck

por Babu, Govind, Bahl, Ankur, Bhattacharya, G. S., Bhowmik, K. T., Dattatraya, P. S., Ghadyalpatil, Nikhil, Karandikar, S. M., Kulkarni, Padmaj, Sridharan, Nithya, Parikh, Purvish, Prabhash, Kumar, Raja, T., Rajasundaram, S., Subramanian, S., Talapatra, Kaustav, Vaid, Ashok
Publicado 2017